InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,151.92
(
0.42%
)
Post# of 34575
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Phantom Lord

Send PM Follow Ignore
Followers 33
Posts 2042
Boards Moderated 0
Alias Born 11/06/2011

Phantom Lord

Re: dmj3430 post# 24076

Thursday, 07/12/2018 1:04:00 PM

Thursday, July 12, 2018 1:04:00 PM

Post# of 34575
A little confusion. IR thought I was requesting info on the TNBC data in general, not in regard to a specific trial. Their response to the specific trial, NCT02593227, is below:

If you take a look at our earnings call, (HERE) we had a couple of months ago, Dr. Kenney stated, "We are currently analyzing the data and anticipate reporting results in the third quarter this year. The interim analysis will focus on patient immune responses following vaccination with varying doses of TPIV200 for patients treated with or without preliminary type of hospital line."

So within the next couple of months we should get some data on this trial.

Friends don't let friends place market orders

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MRKR News
More MRKR News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!